Greater adaptivity or greater control? Adaptation of IOR portfolios in response to technological change

T. de Leeuw, V.A. Gilsing, Geert Duijsters

Research output: Contribution to journalArticleScientificpeer-review

Abstract

This paper addresses the question of how firms accomplish the strategic task of adapting their entire set of IORs (interorganizational relationships) to changing environmental conditions. To study this, we move beyond the focus on collaboration with individual partners (the dyadic perspective) that has been the dominant emphasis in the literature until now. Instead, we view the firms’ portfolios through the lens of the different modes of IOR engaged in (licensing agreements, non-equity alliances, venture capital investments, minority investments, joint ventures, and mergers & and acquisitions). We study the role of environmental change within the high-tech setting of the bio-pharmaceutical industry and distinguish between industry technological change and firm-specific technological change.
Original languageEnglish
Pages (from-to)1586-1600
JournalResearch Policy: A Journal devoted to Research Policy, Research Management and Planning
Volume48
Issue number6
DOIs
Publication statusPublished - 1 Jul 2019

Fingerprint

Drug products
Lenses
Industry
Adaptivity
Technological change
Interorganizational relationships
Venture capital
Biopharmaceutical industry
Alliances
High-tech
Environmental conditions
Capital investment
Minorities
Environmental change
Licensing
Joint ventures
Mergers

Keywords

  • interorganizational relationships
  • technological change
  • environmental uncertainty
  • prospect theory
  • alliance portfolios
  • adaptive behavior
  • organizational adaption

Cite this

@article{96fa25d63523413d851cc02ad5a2d0b6,
title = "Greater adaptivity or greater control? Adaptation of IOR portfolios in response to technological change",
abstract = "This paper addresses the question of how firms accomplish the strategic task of adapting their entire set of IORs (interorganizational relationships) to changing environmental conditions. To study this, we move beyond the focus on collaboration with individual partners (the dyadic perspective) that has been the dominant emphasis in the literature until now. Instead, we view the firms’ portfolios through the lens of the different modes of IOR engaged in (licensing agreements, non-equity alliances, venture capital investments, minority investments, joint ventures, and mergers & and acquisitions). We study the role of environmental change within the high-tech setting of the bio-pharmaceutical industry and distinguish between industry technological change and firm-specific technological change.",
keywords = "interorganizational relationships, technological change, environmental uncertainty, prospect theory, alliance portfolios, adaptive behavior, organizational adaption",
author = "{de Leeuw}, T. and V.A. Gilsing and Geert Duijsters",
year = "2019",
month = "7",
day = "1",
doi = "10.1016/j.respol.2018.12.003",
language = "English",
volume = "48",
pages = "1586--1600",
journal = "Research Policy: A Journal devoted to Research Policy, Research Management and Planning",
issn = "0048-7333",
publisher = "Elsevier Science BV",
number = "6",

}

Greater adaptivity or greater control? Adaptation of IOR portfolios in response to technological change. / de Leeuw, T.; Gilsing, V.A.; Duijsters, Geert.

In: Research Policy: A Journal devoted to Research Policy, Research Management and Planning, Vol. 48, No. 6, 01.07.2019, p. 1586-1600.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Greater adaptivity or greater control? Adaptation of IOR portfolios in response to technological change

AU - de Leeuw, T.

AU - Gilsing, V.A.

AU - Duijsters, Geert

PY - 2019/7/1

Y1 - 2019/7/1

N2 - This paper addresses the question of how firms accomplish the strategic task of adapting their entire set of IORs (interorganizational relationships) to changing environmental conditions. To study this, we move beyond the focus on collaboration with individual partners (the dyadic perspective) that has been the dominant emphasis in the literature until now. Instead, we view the firms’ portfolios through the lens of the different modes of IOR engaged in (licensing agreements, non-equity alliances, venture capital investments, minority investments, joint ventures, and mergers & and acquisitions). We study the role of environmental change within the high-tech setting of the bio-pharmaceutical industry and distinguish between industry technological change and firm-specific technological change.

AB - This paper addresses the question of how firms accomplish the strategic task of adapting their entire set of IORs (interorganizational relationships) to changing environmental conditions. To study this, we move beyond the focus on collaboration with individual partners (the dyadic perspective) that has been the dominant emphasis in the literature until now. Instead, we view the firms’ portfolios through the lens of the different modes of IOR engaged in (licensing agreements, non-equity alliances, venture capital investments, minority investments, joint ventures, and mergers & and acquisitions). We study the role of environmental change within the high-tech setting of the bio-pharmaceutical industry and distinguish between industry technological change and firm-specific technological change.

KW - interorganizational relationships

KW - technological change

KW - environmental uncertainty

KW - prospect theory

KW - alliance portfolios

KW - adaptive behavior

KW - organizational adaption

U2 - 10.1016/j.respol.2018.12.003

DO - 10.1016/j.respol.2018.12.003

M3 - Article

VL - 48

SP - 1586

EP - 1600

JO - Research Policy: A Journal devoted to Research Policy, Research Management and Planning

JF - Research Policy: A Journal devoted to Research Policy, Research Management and Planning

SN - 0048-7333

IS - 6

ER -